The HMH PGY1 Pharmacy Residency program is designed to develop compassionate clinical pharmacy specialists who are able to adapt to the ever-changing healthcare landscape, through progressive clinical, leadership, and research experiences. Graduates of the program will be prepared to meet the expectations of a clinical pharmacist-level position or a PGY2 residency training position, and seamlessly become an integral member of a multidisciplinary patient care team.
The program provides 10 months of clinical rotations, including required rotations in Cardiology, Critical Care, Internal Medicine, Infectious Diseases, and Medication Safety/Management. Additionally, the resident will also have access to a variety of elective rotations offered in Hematology/Oncology, Neurology, Solid Organ Transplant, and Psychiatry.
Training alongside over 50 clinical pharmacists and 21 other residents, the PGY1 resident will have ample teaching opportunities including providing instruction and mentorship to Doctor of Pharmacy Students on rotation. Additionally, the resident will conduct a continuous quality improvement project as well as a research project to be submitted for publication. The resident will also provide an ACPE-accredited CE program and can participate in an optional teaching certificate program through the University of Houston College of Pharmacy.
Houston Methodist Hospital (HMH) is a 900+ bed tertiary teaching hospital and is an academic affiliate of Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences, New York Presbyterian Hospital, and many colleges of pharmacy. HMH is consistently ranked in multiple specialties by U.S. News and World Report and recognized as the No.1 hospital in Texas and Gulf Coast. HMH is included on Forbes magazine's list of "America's Best Employers".